CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Technological advancements and the development of new 3D in vitro models
4.1.2. Increasing focus on developing alternatives for animal testing models
4.1.3. Significant rise in research funding and venture capital investments
4.1.4. Growing incidence of preventable chronic diseases
4.2. Market Restraints & Challenges
4.2.1. Lack of skilled professionals
4.2.2. Unfavourable payment models
4.3. Market Opportunities
4.3.1. Applications in regenerative medicine, tissue engineering, and oncology research
4.3.2. Growing number of drug discovery activities
CHAPTER 5. GLOBAL IN VITRO LUNG MODEL MARKET – BY TYPE
5.1 Introduction
5.2 2D Cell Models
5.3 3D Cell Models
5.3.1Commercial 3D cell models
5.3.2In house 3D cell models
CHAPTER 6. GLOBAL IN VITRO LUNG MODEL MARKET – BY APPLICATION
6.1 Introduction
6.2 Applications of 2D Models
6.3 Applications of 3D Models
CHAPTER 7. GLOBAL IN VITRO LUNG MODEL MARKET - BY GEOGRAPHY
7.1. Introduction
7.2. North America
7.2.1. U.S.
7.2.2. Canada
7.2.3. Mexico
7.2.4. Costa Rica
7.3. South America
7.3.1. Brazil
7.3.2. Argentina
7.3.3. Chile
7.3.4. Columbia
7.3.5. Others
7.4. Europe
7.4.1. U.K.
7.4.2. Germany
7.4.3. France
7.4.4. Italy
7.4.5. Spain
7.4.6. Russia
7.4.7. Netherlands
7.4.7. Switzerland
7.4.8. Poland
7.4.9. Others
7.5. APAC
7.5.1. China
7.5.2. Japan
7.5.3. India
7.5.4. South Korea
7.5.5. Australia & New Zealand
7.5.6. Malaysia
7.5.7. Singapore
7.5.8. Others
7.6. Middle East & Africa
7.6.1. UAE
7.6.2. Saudi Arabia
7.6.3. Iran
7.6.4. Iraq
7.6.5. Qatar
7.6.6. South Africa
7.6.7. Algeria
7.6.8. Morocco
7.6.9. Nigeria
7.6.10. Egypt
7.6.11. Others
CHAPTER 8. GLOBAL IN VITRO LUNG MODEL MARKET - COMPANY
PROFILES
8.1. Epithelix SAS.
8.2. MatTek Corporation
8.3. Lonza Group.
8.4. MIMETAS.
8.5. InSphero AG.
8.6. Emulate, Inc.
8.7. CN Bio Innovations.
8.8. Oncotheis.
8.9. TissUse GmbH.
8.10. American Type Culture Collection.
8.11. AlveoliX AG.
8.12. Well Doc Inc.
8.13. Twine Health, Inc.
8.14. Proteus Digital Health.
8.15. Zest Health, LLC.
CHAPTER 9. GLOBAL IN VITRO LUNG MODEL MARKET - COMPETITIVE
LANDSCAPE
9.1. Market Share Analysis
9.2. Strategies adopted by top companies
9.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 10. MARKET INSIGHTS
10.1. Industry Experts Insights
10.2. Analysts Opinions
10.3. Investment Opportunities
CHAPTER 11. APPENDIX
11.1. List of Tables
11.2. List of Figures
